-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We raise our target price by $25 to $365 using a forward P/E of 15.9x our 2026 earnings estimate that is near the three-year historical average of 16.1x on normalized earnings. We increase our EPS estimates in 2026 by $1.00 to $23.00 and 2027's by $0.75 to $23.75 on projected revenue of $195.9B (prior $192.0B) and $203.7B ($199.5B) respectively. Both our EPS and revenue estimates take into account the seasonal swing across JPM's businesses whereby the first quarter is historically the strongest period. Despite worries surrounding the Iran-U.S. conflict, we are positive on the outlook for the capital markets in 2026, which should favorably impact investment banking fees (equity underwriting and M&A advisory fees), and an elevated equity market bolstering management fee income for the Asset & Wealth Management segment. We anticipate that JPM and peers will benefit from more constructive bank regulation in the Fed's bank stress tests to be released late June. We expect a higher return of capital.